investment resilience
- Phronimos

- Feb 5
- 2 min read
The recent turmoil in some corners of the equity market and certain other asset classes has had virtually no impact on the value of our portfolio, which remains up just under 2% in 2026 to date.
The Nasdaq is down nearly 5% over the past five trading sessions and since the beginning of the year the S&P500 Software sub-sector is down around 20% amid fears of AI disruption.
S&P500 Software and Services Index - 2026 YTD

Firms that rely on providing data and analytics, and which have formerly been viewed as high quality businesses have been similarly hard hit. And despite AI doing the disrupting investors have also been shaken by the truly extraordinary levels of capital investment the hyperscalers are planning for 2026 - Alphabet's $180bn and Amazon's $200bn being the most notable, management's confidence in the return on that investment notwithstanding.
And even the previous winners of that capital spending bacchanalia, such as Nvidia, have not seen the usual positive response gargantuan investments in IT infrastructure given increased competition from Alphabet (interestingly, TSMC, as the single most vital node in the entire semiconductor supply chain has remained unperturbed). Weakness has also spilled over in Bitcoin and precious metals, which one would previously have assumed have nothing to do with either software or AI.
The most obvious reason for the resilience of our portfolio is the fact we hold virtually no technology, software, precious metals and certainly nothing related to crypto. Our portfolio didn't benefit as these assets surged last year and it hasn't suffered in this recent weakness.
That's not to say our holdings won't be swept up in a scenario of broader market stress or that they don't face their own idiosyncratic risks. The latter will be much more significant for our performance given the relative concentration of our holdings.
We normally reserve disclosure of our largest 10 holdings for our quarterly investor letters, however, to better illustrate the above point the list is provided below as at 31 January.
Robertet SA | 11.8% |
Fielmann Group AG | 11.5% |
Berkshire Hathaway Inc | 9.6% |
Guaranty Trust Holding Company plc | 7.6% |
Spirax Group plc | 7.3% |
Novonesis A/S | 7.2% |
CarMax Inc | 5.8% |
Jeronimo Martins SGPS | 5.6% |
Halozyme Therapeutics Inc | 5.1% |
Chevron Corp | 5.1% |
As should be clear from the below the majority of our holdings are small to medium-sized companies concentrated in the consumer or industrial sectors with one or two exceptions. Chevron, for instance, is the result of our investment in Hess Corporation that was acquired.



Comments